ArticleFrontiers in pharmacology2022

Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review.

Sirui Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.